Evoke Pharma (EVOK) Misses Q4 EPS by 49c

Evoke Pharma (NASDAQ: EVOK) reported Q4 EPS of ($0.49). Revenue for the quarter came in at $3.3 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• SpaceX (SPCX) call put ratio 1 calls to 1.1 puts as share price at $155
• DoE Announces Conditional $17.5B Financing to Support Westinghouse Nuclear Reactor Deployment